News NEXTBIOMEDICAL Secures the US FDA’s IDE Approval of Nexsphere-F to Use it in Genicular Artery Embolization (GAE) for Knee OsteoarthritisBySenior EditorJanuary 16, 20250Comments
INSIGHTS+ Know Your Investor: RA Capital Management (January’25 Edition)ByPrince GiriJanuary 16, 20251Comment
News REGENXBIO Join Forces with Nippon Shinyaku to Develop and Commercialize RGX-121 and RGX-111 for Mucopolysaccharidosis (MPS)BySenior EditorJanuary 15, 20250Comments
News HUTCHMED’ Orpathys (Savolitinib) Receives the NMPA’s Full Approval for Locally Advanced or Metastatic MET Exon 14 NSCLCByRidhi RastogiJanuary 15, 20250Comments
News Neurogen Partners with Linus Health to Develop Early Detection Technology for Mild Cognitive Impairment and Dementia due to Alzheimer’s DiseaseByRidhi RastogiJanuary 15, 20250Comments
News Regeneron Reports Interim Data from P-III (C-POST) Trial of Libtayo Adjuvant to Treat High-Risk Cutaneous Squamous Cell Carcinoma (CSCC)ByRidhi RastogiJanuary 15, 20250Comments
News AbbVie and Simcere Zaiming Collaborate to Develop SIM0500 for Treating Multiple MyelomaByRidhi RastogiJanuary 15, 20250Comments
News AstraZeneca and Daiichi Sankyo Report the US FDA’s BLA Acceptance of Datopotamab Deruxtecan with Priority Review for EGFR-mutated NSCLCByRidhi RastogiJanuary 15, 20250Comments
